Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
221.5 USD | -0.56% | +1.83% | -14.40% |
05-09 | MOVES -Lazard hires veteran healthcare dealmaker Colocci as vice chairman | RE |
05-08 | Redburn Atlantic Adjusts Price Target on Biogen to $235 From $275, Keeps Neutral Rating | MT |
ETFs positioned on Biogen Inc.
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.10% | 0 M€ | +11.62% | - | |
0.09% | 29 M€ | -.--% | - | |
0.09% | 322 M€ | +13.88% | ||
0.09% | 1 M€ | -.--% | ||
0.08% | 414 M€ | +11.90% | - | |
0.08% | 1,006 M€ | -.--% | ||
0.08% | 0 M€ | +12.13% | - | |
0.08% | 14 M€ | +16.19% | - | |
0.07% | 0 M€ | 0.00% | - | |
0.07% | 786 M€ | -.--% | ||
0.07% | 23 M€ | -.--% | - | |
0.07% | 607 M€ | +0.05% | ||
0.07% | 1,166 M€ | +0.26% | ||
0.07% | 0 M€ | +8.67% | ||
0.07% | 0 M€ | +6.85% | - | |
0.07% | 0 M€ | +9.18% | - | |
0.06% | 0 M€ | +18.92% | ||
0.06% | 0 M€ | +8.24% | - | |
0.06% | 206 M€ | -.--% | ||
0.06% | 0 M€ | +8.70% | - | |
0.06% | 284 M€ | -.--% | ||
0.05% | 0 M€ | +5.79% | - | |
0.05% | 0 M€ | +5.63% | - | |
0.04% | 0 M€ | +0.34% | - | |
0.04% | 2 M€ | +3.16% | - |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.40% | 32.25B | |
-2.61% | 89.08B | |
+3.55% | 40.9B | |
+55.89% | 25.14B | |
-15.96% | 15.39B | |
-15.50% | 11.91B | |
-41.29% | 11.89B | |
-11.75% | 11.64B | |
+7.87% | 9.03B | |
-3.16% | 8.62B |
- Stock Market
- Equities
- BIIB Stock
- Funds and ETFs Biogen Inc.